Manchester Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$291 Hold
3
﹤0.01% 1258
2025
Q4
$319 Hold
3
﹤0.01% 1285
2025
Q3
$382 Hold
3
﹤0.01% 1217
2025
Q2
$368 Hold
3
﹤0.01% 1125
2025
Q1
$304 Hold
3
﹤0.01% 1109
2024
Q4
$278 Hold
3
﹤0.01% 1114
2024
Q3
$290 Sell
3
-2
-40% -$180 ﹤0.01% 1118
2024
Q2
$429 Hold
5
﹤0.01% 1071
2024
Q1
$413 Hold
5
﹤0.01% 957
2023
Q4
$334 Hold
5
﹤0.01% 946
2023
Q3
$336 Hold
5
﹤0.01% 929
2023
Q2
$339 Hold
5
﹤0.01% 907
2023
Q1
$271 Hold
5
﹤0.01% 1037
2022
Q4
$299 Buy
+5
New +$272 ﹤0.01% 962
2022
Q2
Sell
-36
Closed -$2K 1014
2022
Q1
$2K Hold
36
﹤0.01% 811
2021
Q4
$2K Buy
+36
New +$1.86K ﹤0.01% 827
2019
Q2
Sell
-823
Closed -$38K 577
2019
Q1
$38K Buy
+823
New +$41.7K ﹤0.01% 439

Other funds holding EHC

Manchester Capital Management's EHC Position: Q1 2026 in Review

Manchester Capital Management held its Encompass Health (EHC) position steady in Q1 2026 at 3 shares worth $291. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Manchester Capital Management first reported a position in EHC in Q1 2019 and has held it in 17 quarters since. The position peaked at $38K in Q1 2019. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Manchester Capital Management held 3 shares of Encompass Health worth $291 as of Q1 2026.
  • Manchester Capital Management left its Encompass Health share count unchanged in Q1 2026.
  • Encompass Health made up ﹤0.01% of Manchester Capital Management's portfolio in Q1 2026, its #1258 holding.
  • Manchester Capital Management first reported a position in Encompass Health in Q1 2019 and has held it in 17 quarters since.
  • Manchester Capital Management's Encompass Health position peaked at $38K in Q1 2019.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.